# RedHill Biopharma Ltd.: Form 6-K, filed Mar 5, 2026

- Company: [RedHill Biopharma Ltd.](/companies/rdhl.md) (CIK 1553846)
- Form: 6-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 09:00 ET
- Period: 2026-03-05
- Accession: 0001178913-26-000751
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553846/000117891326000751/zk2634498.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553846/000117891326000751/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553846/000117891326000751/zk2634498.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001178913-26-000751. Last ingested by Listed: Nov 2, 2026, 07:05 ET. No prices; not investment advice.